GLP-1s tied to 37% higher hair loss risk, study finds

A recent study published in The BMJ reveals that GLP-1 receptor agonists, commonly prescribed for Type 2 diabetes, are linked to a 37% higher risk of hair loss compared to other diabetes medications. Researchers at Penn Medicine analyzed electronic health records from patients who started these drugs between January 2019 and the present. This finding is significant as it highlights a potential side effect that could impact patient choice and treatment plans, especially given the growing use of GLP-1s for their effectiveness in managing blood sugar levels.